BCR‐induced superoxide negatively regulates B‐cell proliferation and T‐cell‐independent type 2 Ab responses
SM Richards, EA Clark - European journal of immunology, 2009 - Wiley Online Library
SM Richards, EA Clark
European journal of immunology, 2009•Wiley Online LibrarySuperoxide and its derivatives have been implicated as secondary messenger molecules
that influence signaling cascades in non‐phagocytes. B lymphocytes produce superoxide
after BCR ligation. We found that these ROS regulate B‐cell signaling and entry into the cell
cycle. B cells from mice deficient in the gp91phox subunit of the NADPH oxidase complex
are unable to generate ROS after BCR ligation. However, after BCR stimulation, more
gp91phox KO B cells enter the G1 stage of the cell cycle and proliferate than WT B cells …
that influence signaling cascades in non‐phagocytes. B lymphocytes produce superoxide
after BCR ligation. We found that these ROS regulate B‐cell signaling and entry into the cell
cycle. B cells from mice deficient in the gp91phox subunit of the NADPH oxidase complex
are unable to generate ROS after BCR ligation. However, after BCR stimulation, more
gp91phox KO B cells enter the G1 stage of the cell cycle and proliferate than WT B cells …
Abstract
Superoxide and its derivatives have been implicated as secondary messenger molecules that influence signaling cascades in non‐phagocytes. B lymphocytes produce superoxide after BCR ligation. We found that these ROS regulate B‐cell signaling and entry into the cell cycle. B cells from mice deficient in the gp91phox subunit of the NADPH oxidase complex are unable to generate ROS after BCR ligation. However, after BCR stimulation, more gp91phox KO B cells enter the G1 stage of the cell cycle and proliferate than WT B cells. BCR ligation leads to a more rapid decrease in p27Kip1 levels in gp91phox KO B cells. Gp91phox KO mice display enhanced T‐cell‐independent type 2, but normal T‐dependent Ab responses. ROS‐dependent regulation of BCR‐induced proliferation may help modulate the size of the humoral response to T‐cell‐independent type 2 Ag immunization.
